Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis
AUTHOR: E. J. Bass, A. Pantovic, M. J. Connor, S. Loeb, A. R. Rastinehad, M. Winkler, Rhian Gabe & H. U. Ahmed
Multiparametric MRI localizes cancer in the prostate, therefore allowing for MRI guided biopsy (MRIGB) 43 alongside transrectal ultrasound-guided systematic biopsy (TRUS-GB). Three MRIGB approaches exist; visual estimation (COG-TB); fusion software-assisted (FUS-TB) and lastly MRI ‘in-bore’ biopsy (IB-TB). Although it is unknown whether any of these are superior.
1. REFLECT – Before reading this module, consider the following: Will this clinical area be relevant to my practice?
2. IDENTIFY – If the answer is no, I may still be interested in the area. However, the article may not contribute towards my continuing professional development (CPD). If the answer is yes, I should therefore identify any knowledge gaps in the clinical area.
3. PLAN – If I have identified a knowledge gap – will this article satisfy those needs? Will more reading be required in addition to this?
4. EVALUATE – Did this article meet my learning needs – and in addition to this how has my practise changed as a result? Have I identified further learning needs?
5. WHAT NEXT – At this time you may like to record your learning for future use or assessment.
Lastly, follow the 4 previous steps, log and record your findings.
Published by HPN. Download your copy from www.irishpharmacytraining.ie
Disclaimer: All material published is copyright. Therefore without permission from the publishers and author, no part of this can be used in any other publication.
60 Second Summary on Prostate Cancer CPD:
We conducted a systematic review and meta-analysis to address three questions. Firstly, whether MRI-GB is superior to TRUS-GB at detecting clinically significant PCa (csPCa). Secondly, whether MRI-GB is superior to TRUS-GB at avoiding detection of insignificant PCa. Thirdly and lastly, whether any MRI-GB strategy is superior at detecting csPCa.
A systematic literature review from 2015 to 2019 was performed in accordance with the START recommendations. Studies reporting PCa detection rates, employing MRI-GB and TRUSGB were included and evaluated using the QUADAS-2 checklist. 1553 studies were found, of which 43 were included in the meta-analysis.
For csPCa, MRI-GB was superior in detection to TRUS-GB (0.83 vs. 0.63 [p = 0.02]). MRI-GB was superior in detection to TRUS-GB at avoiding detection of insignificant PCa. No MRIGB technique was superior at detecting csPCa (IB-TB 0.87; COG TB 0.81; FUS-TB 0.81, [p = 0.55]). Observed was significant heterogeneity between the included studies.
In patients with suspected PCa on MRI, MRI-GB offers superior rates of csPCa detection. It reduces detection of insignificant PCa compared to TRUS-GB. In addition to this no individual MRI-GB technique was found to be better in csPCa detection. Prospective adequately powered randomized controlled trials are required.
Sign up to receive the full CPD HERE